View in EDS

Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.

Saved in:

Bibliographic Details
Title:	Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.
Authors:	Heeke AL; Levine Cancer Institute, Atrium Health, Charlotte, NC., Elliott A; Caris Life Sciences, Phoenix, AZ., O'Keefe K; Levine Cancer Institute, Atrium Health, Charlotte, NC., Livasy C; Levine Cancer Institute, Atrium Health, Charlotte, NC., Symanowski JT; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC., Steiner MR; Levine Cancer Institute, Atrium Health, Charlotte, NC., Kang IM; City of Hope Orange County, Irvine, CA., Hoon DSB; Saint John's Cancer Institute, Saint John's Health Center, Providence Health Systems, Santa Monica, CA., Walker P; Caris Life Sciences, Phoenix, AZ., Sledge GW; Caris Life Sciences, Phoenix, AZ., Radovich M; Caris Life Sciences, Phoenix, AZ., Pohlmann PR; University of Texas MD Anderson Cancer Center, Houston, TX., Swain SM; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC., Tan AR; Levine Cancer Institute, Atrium Health, Charlotte, NC.
Source:	JCO precision oncology [JCO Precis Oncol] 2025 Jan; Vol. 9, pp. e2300719. Date of Electronic Publication: 2025 Jan 31.
Publication Type:	Journal Article
Journal Info:	Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2473-4284
DOI:	10.1200/PO.23.00719